Targeted therapy of B cell malignances with CAR-T cells of defined composition

Investigator from Dana–Farber Cancer Institute

Nursing Oncology Capacity Building through Fellowship Programs in Rwanda and Haiti

Non-Hodgkin lymphoma

Theodore S Jardetzky

Inhibitors of the Epstein-Barr Virus Entry Machinery

Non-Hodgkin lymphoma

Brenda Marie Sandmaier

Alpha Radioimmunotherapy for Lymphoma Treatment

Non-Hodgkin lymphoma

Alejandro Gutierrez

Discovery and targeting of apoptosis resistance mechanisms in high-risk T-ALL

Leukaemia

Suzanne McGoldrick

Burkitt Lymphoma Clinical Care Project

Non-Hodgkin lymphoma

Pediatric oncology or childhood cancer Hematology and hematologic malignancies Pathology

Nathanael S Gray

MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Martha Lassiter

Duke University Nursing Oncology Training Exchange with Tata Memorial Hospital

Leukaemia Non-Hodgkin lymphoma

Catherine Ju-Ying Wu

(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL

Leukaemia

Helen E. Heslop

Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT

Leukaemia